tiprankstipranks
Trending News
More News >
EcoSynthetix Inc. J (TSE:ECO)
TSX:ECO
Advertisement

EcoSynthetix (ECO) AI Stock Analysis

Compare
12 Followers

Top Page

TSE:ECO

EcoSynthetix

(TSX:ECO)

Select Model
Select Model
Select Model
Neutral 51 (OpenAI - 4o)
Rating:51Neutral
Price Target:
C$4.00
▼(-8.26% Downside)
EcoSynthetix's overall stock score reflects a challenging financial landscape with positive revenue growth but significant profitability and cash flow issues. The earnings call provided a positive outlook with strong sales growth, but concerns about profitability remain. Technical indicators suggest a neutral market sentiment, while valuation metrics highlight the company's lack of profitability.
Positive Factors
Market Diversification
EcoSynthetix's diversification across multiple markets reduces dependency on any single sector, enhancing resilience and growth potential.
Strategic Partnerships
Strategic partnerships, like with R&M Group, expand market reach and customer base, supporting long-term revenue growth and competitive positioning.
Cash Management
Strong cash reserves provide financial stability and flexibility for strategic investments, supporting sustainable business operations.
Negative Factors
Profitability Challenges
Declining gross profit margins indicate rising costs and pressure on profitability, which could affect long-term financial health if not addressed.
Increased Operating Expenses
Rising SG&A expenses can erode margins and profitability, necessitating cost control measures to maintain financial performance.
Cash Flow Concerns
Negative free cash flow indicates potential cash management issues, limiting the ability to invest in growth opportunities or weather downturns.

EcoSynthetix (ECO) vs. iShares MSCI Canada ETF (EWC)

EcoSynthetix Business Overview & Revenue Model

Company DescriptionEcoSynthetix (ECO) is a leading provider of sustainable materials, specializing in the production of bio-based and renewable synthetic materials. The company operates within the green chemistry sector and focuses on creating eco-friendly alternatives to traditional petroleum-based products. EcoSynthetix's core offerings include biopolymers and other sustainable materials that are used in various applications, such as packaging, textiles, and construction, promoting environmental sustainability and reducing carbon footprints.
How the Company Makes MoneyEcoSynthetix generates revenue primarily through the sale of its bio-based synthetic materials to manufacturers in diverse industries, including packaging, textiles, and consumer goods. The company employs a revenue model that includes direct sales, long-term contracts, and partnerships with key players in these sectors. Significant revenue streams are derived from bulk sales to large manufacturers looking to incorporate sustainable materials into their production processes. Additionally, EcoSynthetix may engage in collaborative projects with industry partners to develop custom solutions, further enhancing its revenue potential. The growing demand for environmentally friendly products and regulatory pressures for sustainability create opportunities for the company to expand its market share and increase earnings.

EcoSynthetix Earnings Call Summary

Earnings Call Date:Nov 06, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Mar 04, 2026
Earnings Call Sentiment Positive
The call presented a positive outlook with strong sales growth and market diversification, particularly in pulp and tissue markets, as well as progress in wood composites and personal care. However, there were concerns about declining gross profit percentage and increased SG&A expenses. Despite these challenges, the company's strategic market positioning and operational efficiencies indicate a strong potential for future growth.
Q3-2025 Updates
Positive Updates
Sales Growth and Market Diversification
Sales were up 11% year-over-year, driven by strong demand in key end markets such as pulp, tissue, wood composites, and personal care.
Increase in Pulp Market Potential
The demand for strength aids from a global pulp manufacturer increased from approximately $1 million to more than $3 million annually, with potential market opportunities exceeding $50 million at this customer.
New Wins in Tissue Market
Won 2 new tissue accounts during the quarter through a partnership with the R&M Group.
Progress in Wood Composites
Increased demand from a key strategic account, with usage of binders across more SKUs at the first mill and ongoing trials at a second mill.
Positive Momentum in Personal Care
Increased demand from partner Dow, with all-natural formulations gaining traction with smaller brands of top 10 players.
Operational Efficiency Improvements
Internalizing North American production led to productivity improvements and increased cycle time in commercial production and R&D.
Cash Management and Strategic Investment
Managed cash reserves responsibly with $30.4 million in cash and term deposits, investing $1 million to retire shares and increasing working capital.
Negative Updates
Decline in Gross Profit Percentage
Gross profit as a percentage of sales declined to 34.2%, down from 36.8% in the previous year, primarily due to higher manufacturing costs.
Increased SG&A Expenses
SG&A expenses rose to $1.8 million from $1.5 million the previous year, driven by higher salary, benefit costs, and repairs and maintenance.
Decrease in Adjusted EBITDA
Adjusted EBITDA decreased to $200,000 from $360,000 in the same period in 2024, due to higher operating expenses.
Company Guidance
During the EcoSynthetix 2025 Third Quarter Results Conference Call, the company provided several key metrics indicating growth and progress across its core markets. Sales increased by 11% year-over-year, driven by strong demand in pulp, tissue, and wood composites, with volumes in these segments exceeding the overall sales growth rate. The company's gross profit margin was reported at 34.2%, down from 36.8% in the same period in 2024, attributed to higher manufacturing costs due to product mix. Notably, the demand for EcoSynthetix’s SurfLock strength aids from a major global pulp manufacturer increased significantly, with their annual run rate on the first line growing from $1 million to over $3 million. EcoSynthetix also achieved two new tissue account wins during the quarter, partly through their collaboration with the European distributor, R&M Group. In personal care, the company observed an uptick in demand from its partner Dow, signaling potential growth in this market segment. Financially, net sales for the quarter were $5.8 million, with SG&A expenses rising to $1.8 million and R&D expenses declining to $390,000. Adjusted EBITDA was reported at $200,000 for the quarter, and the company maintained a cash reserve of $30.4 million as of September 30, 2025.

EcoSynthetix Financial Statement Overview

Summary
EcoSynthetix shows a mixed financial performance. Revenue growth is positive at 10.18%, but profitability remains a challenge with negative net profit and EBIT margins. The balance sheet is strong with low leverage, but cash flow management is concerning due to negative free cash flow growth.
Income Statement
45
Neutral
EcoSynthetix shows a mixed performance in its income statement. The TTM data indicates a positive revenue growth rate of 10.18%, suggesting some recovery in sales. However, the company struggles with profitability, as evidenced by negative net profit and EBIT margins. The gross profit margin remains relatively stable at around 28%, but the negative EBIT and EBITDA margins highlight ongoing operational challenges.
Balance Sheet
60
Neutral
The balance sheet reflects a strong equity position with a low debt-to-equity ratio of 0.0022, indicating minimal leverage and financial risk. However, the return on equity is negative, suggesting inefficiencies in generating returns from equity investments. The equity ratio remains healthy, underscoring a solid capital structure.
Cash Flow
40
Negative
Cash flow analysis reveals challenges, with a significant decline in free cash flow growth and negative free cash flow to net income ratio. The operating cash flow to net income ratio is positive, indicating some ability to generate cash from operations, but overall cash flow management remains a concern.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue19.71M18.54M12.66M19.03M18.16M13.66M
Gross Profit5.60M5.31M2.78M4.15M3.97M2.74M
EBITDA-978.35K-2.02M-3.24M-1.77M-1.86M-1.57M
Net Income-559.22K-1.37M-2.82M-1.32M-3.12M-1.80M
Balance Sheet
Total Assets40.27M41.28M42.84M48.19M50.98M51.72M
Cash, Cash Equivalents and Short-Term Investments30.73M32.20M33.28M25.86M42.23M41.98M
Total Debt85.75K237.79K584.36K819.47K1.08M1.31M
Total Liabilities1.65M1.94M1.87M3.14M3.18M2.25M
Stockholders Equity38.62M39.35M40.97M45.06M47.80M49.47M
Cash Flow
Free Cash Flow-162.69K236.11K-1.31M-5.17M94.09K-21.37K
Operating Cash Flow458.34K1.10M316.99K-4.90M474.07K226.78K
Investing Cash Flow3.22M3.47M2.00M-31.15M24.69M9.75M
Financing Cash Flow-1.98M-1.73M-2.27M-1.51M474.28K-1.43M

EcoSynthetix Technical Analysis

Technical Analysis Sentiment
Positive
Last Price4.36
Price Trends
50DMA
4.32
Positive
100DMA
4.26
Positive
200DMA
4.27
Positive
Market Momentum
MACD
-0.02
Positive
RSI
51.27
Neutral
STOCH
68.06
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:ECO, the sentiment is Positive. The current price of 4.36 is below the 20-day moving average (MA) of 4.38, above the 50-day MA of 4.32, and above the 200-day MA of 4.27, indicating a neutral trend. The MACD of -0.02 indicates Positive momentum. The RSI at 51.27 is Neutral, neither overbought nor oversold. The STOCH value of 68.06 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:ECO.

EcoSynthetix Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
54
Neutral
C$1.19B-126.76-87.47%331.08%15.77%
53
Neutral
C$136.50M-16.67-92.59%6.29%-3.71%
51
Neutral
C$252.00M-311.59-2.11%30.76%52.23%
50
Neutral
C$115.66M-20.70-2.95%3.41%5.06%93.02%
50
Neutral
C$702.19M-48.34-1.61%2.35%8.04%-195.66%
45
Neutral
C$183.97M-16.79-64.59%56.03%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:ECO
EcoSynthetix
4.19
0.19
4.75%
TSE:BOS
Airboss of America
4.10
0.47
12.95%
TSE:NANO
Nano One Materials
1.49
0.66
79.52%
TSE:NEO
Neo Performance Materials Inc
17.33
8.97
107.30%
TSE:GMG
Graphene Manufacturing Group Ltd
1.24
0.65
110.17%
TSE:HG
Hydrograph Clean Power
2.81
2.63
1461.11%

EcoSynthetix Corporate Events

EcoSynthetix Earnings Call Highlights Growth and Challenges
Nov 9, 2025

EcoSynthetix Inc. recently held its earnings call, presenting a generally positive outlook with notable sales growth and market diversification. The company has made significant strides in the pulp and tissue markets, as well as progress in wood composites and personal care sectors. Despite some concerns about declining gross profit percentages and increased SG&A expenses, EcoSynthetix’s strategic market positioning and operational efficiencies suggest strong potential for future growth.

Business Operations and StrategyFinancial Disclosures
EcoSynthetix Sees Growth in Q3 2025 with New European Accounts
Positive
Nov 6, 2025

EcoSynthetix reported a 11% increase in net sales for Q3 2025, driven by higher volumes and new commercial accounts in Europe for its SurfLock™ strength aids. The company maintained a strong balance sheet with $30.4 million in cash and term deposits, and is positioned for long-term growth with strategic partnerships in key markets.

The most recent analyst rating on (TSE:ECO) stock is a Hold with a C$4.50 price target. To see the full list of analyst forecasts on EcoSynthetix stock, see the TSE:ECO Stock Forecast page.

Business Operations and StrategyProduct-Related Announcements
EcoSynthetix Expands European Market with New Tissue Line Contracts
Positive
Oct 6, 2025

EcoSynthetix Inc. has secured two new tissue line contracts in Europe for its bio-based strength aid, SurfLock™, through a partnership with RNM Group. This development highlights the growing recognition of SurfLock™’s value in strengthening paper applications while using cost-effective or recycled materials, enhancing EcoSynthetix’s market position and expanding its reach in the tissue industry.

The most recent analyst rating on (TSE:ECO) stock is a Hold with a C$4.00 price target. To see the full list of analyst forecasts on EcoSynthetix stock, see the TSE:ECO Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 18, 2025